Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.6988653264948796e-40,233.97718631178708,21426.096568312154,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPL23', 'RPS5', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",5.249493858869178e-38,0,0,64
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,8.277774670225562e-27,79.34862385321101,4765.378675707185,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'SLC25A5', 'SLC25A6']",1.2789161865498493e-24,0,0,45
3,Nonalcoholic fatty liver disease WP4396,1.0085287534627437e-18,19.38371791547835,803.2232605897268,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",1.0387846160666261e-16,0,0,39
4,Oxidative phosphorylation WP623,2.9556060063489277e-12,25.97472075249853,689.5591563956908,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFB2', 'ATP5MC3', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1B', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'ATP5MF', 'ATP5ME']",2.2832056399045465e-10,0,0,23
5,Mitochondrial complex I assembly model OXPHOS system WP4324,4.4423402619445983e-10,30.24125874125874,651.2355154726613,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFA3', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAF3']",2.7453662818817615e-08,0,0,18
6,Mitochondrial CIV Assembly WP4922,3.945133486733774e-09,50.165217391304346,970.7362382085847,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX7C', 'COX6B1', 'SCO2', 'COX14']",2.031743745667894e-07,0,0,15
7,Mitochondrial complex III assembly WP4921,8.871748799674591e-06,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.00039162433987134984,0,0,8
8,Cholesterol Biosynthesis Pathway WP197,0.0009179892938951916,19.756849315068493,138.1660648743836,"['IDI1', 'SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'FDFT1']",0.03151763242373491,0,0,6
9,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.0009179892938951916,19.756849315068493,138.1660648743836,"['IDI1', 'SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'FDFT1']",0.03151763242373491,0,0,6
10,Selenium Micronutrient Network WP15,0.0022128565351397953,4.042410285933602,24.71315824815816,"['SELENOM', 'PRDX5', 'GPX4', 'PRDX1', 'SELENOW', 'SELENOK', 'SEPHS2', 'LDLR', 'SELENOH', 'SOD1', 'MSRB1']",0.06837726693581968,0,0,11
11,Eukaryotic Transcription Initiation WP405,0.003397031807998696,16.435897435897434,93.43566456546318,"['TAF13', 'TAF7', 'POLR2I', 'POLR3K', 'POLR2K']",0.09542571169741791,0,0,5
12,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.007083562901986299,6.578767123287672,32.56475425835524,"['IDI1', 'SQLE', 'HMGCS1', 'HMGCR', 'LDLR', 'FDFT1']",0.1824017447261472,0,0,6
13,Androgen receptor signaling pathway WP138,0.011510249753311344,3.764359351988218,16.806047667470256,"['KAT5', 'PRDX1', 'BAG1', 'STUB1', 'BRCA1', 'PARK7', 'CALR', 'FKBP4']",0.22102901426406493,0,0,8
14,Statin inhibition of cholesterol production WP430,0.012238718702117428,13.126279863481228,57.796988219341415,"['SQLE', 'HMGCR', 'LDLR', 'FDFT1']",0.22102901426406493,0,0,4
15,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.012875476559071742,inf,inf,"['HMGCS1', 'HMGCR', 'LDLR']",0.22102901426406493,0,0,3
16,Cellular Proteostasis WP4918,0.012875476559071742,inf,inf,"['VBP1', 'PFDN5', 'PFDN6']",0.22102901426406493,0,0,3
17,Histone Modifications WP2369,0.012875476559071742,inf,inf,"['SET', 'H3F3B', 'H3F3A']",0.22102901426406493,0,0,3
18,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.012875476559071742,inf,inf,"['IDI1', 'HMGCS1', 'HMGCR']",0.22102901426406493,0,0,3
19,Integrated breast cancer pathway WP1984,0.018888011580715493,2.9648881239242684,11.768316561270758,"['GADD45A', 'TRADD', 'ODC1', 'BAX', 'PHB', 'FADD', 'BRCA1', 'HMGCR', 'FAU']",0.30717871465479407,0,0,9
20,Pyrimidine metabolism WP4022,0.027746053384460873,2.9247804505536465,10.48434837217014,"['POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR3K', 'POLR2K', 'NME1', 'POLR2L']",0.42867652478992047,0,0,8
21,Nanomaterial induced apoptosis WP2507,0.029922137557135766,6.559726962457338,23.019109728707953,"['ENDOG', 'BAX', 'CYCS', 'FADD']",0.4402828811978548,0,0,4
22,mRNA Processing WP411,0.03767867521907227,4.102564102564102,13.45091687639615,"['SF3B5', 'LSM7', 'SNRPE', 'SNU13', 'SRSF9']",0.5292141201224241,0,0,5
23,Vitamin B12 metabolism WP1533,0.04247229013208254,9.827938671209541,31.04550900717316,"['CUBN', 'LDLR', 'SOD1']",0.5684152312840788,0,0,3
24,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.05500571350697543,inf,inf,"['COX8A', 'GSTP1']",0.5684152312840788,0,0,2
25,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.05500571350697543,inf,inf,"['H3F3B', 'H3F3A']",0.5684152312840788,0,0,2
26,SARS-CoV-2 mitochondrial interactions WP5038,0.05500571350697543,inf,inf,"['NDUFB9', 'PHB']",0.5684152312840788,0,0,2
27,7q11.23 copy number variation syndrome WP4932,0.055281594265735604,2.3905029678225556,6.921259722074389,"['ATP5F1B', 'EIF4H', 'ATP5PO', 'ATP5MC3', 'ATP5F1D', 'VAMP2', 'ATP5F1E', 'ATP5MC1']",0.5684152312840788,0,0,8
28,Copper homeostasis WP3286,0.05702547627769075,4.370875995449374,12.519312860021602,"['SCO2', 'COX17', 'ATOX1', 'SOD1']",0.5684152312840788,0,0,4
29,DNA IR-double strand breaks and cellular response via ATM WP3959,0.05702547627769075,4.370875995449374,12.519312860021602,"['YAP1', 'KAT5', 'BAX', 'BRCA1']",0.5684152312840788,0,0,4
30,Folate Metabolism WP176,0.05702547627769075,4.370875995449374,12.519312860021602,"['AHCY', 'GPX4', 'LDLR', 'SOD1']",0.5684152312840788,0,0,4
31,Genotoxicity pathway WP4286,0.05702547627769075,4.370875995449374,12.519312860021602,"['RPS27', 'GADD45A', 'TRIAP1', 'PHLDA3']",0.5684152312840788,0,0,4
32,Synaptic Vesicle Pathway WP2267,0.06112886614883204,3.2803418803418802,9.167804630545803,"['SLC32A1', 'PARK7', 'AP2M1', 'VAMP2', 'CPLX3']",0.5723884739390637,0,0,5
33,Melanoma WP4685,0.06112886614883204,3.2803418803418802,9.167804630545803,"['GADD45A', 'BAX', 'CALM3', 'ETS1', 'HRAS']",0.5723884739390637,0,0,5
34,VEGFA-VEGFR2 Signaling Pathway WP3888,0.06652933788592935,1.5468234941564278,4.192065311533331,"['SET', 'SDF2L1', 'SSR4', 'TRPC3', 'RPL13A', 'RPL10A', 'ETS1', 'RPL7', 'DNAJA1', 'LDHA', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'SH3BGRL3', 'RPL26', 'FADD', 'CALR', 'CCT7', 'HRAS', 'SLC25A25']",0.6046342766691815,0,0,22
35,Apoptosis Modulation and Signaling WP1772,0.08603545023927274,2.460616438356164,6.035881925459996,"['ENDOG', 'IL1R1', 'TRADD', 'CYCS', 'BAX', 'FADD']",0.7141372296967234,0,0,6
36,BDNF-TrkB Signaling WP3676,0.08782270138665207,4.911413969335605,11.94669648514971,"['TRPC3', 'HOMER1', 'HRAS']",0.7141372296967234,0,0,3
37,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.08782270138665207,4.911413969335605,11.94669648514971,"['H3F3B', 'H2AFZ', 'H3F3A']",0.7141372296967234,0,0,3
38,p38 MAPK Signaling Pathway WP400,0.08782270138665207,4.911413969335605,11.94669648514971,"['TRADD', 'DDIT3', 'HRAS']",0.7141372296967234,0,0,3
39,Proteasome Degradation WP183,0.09108157601120027,2.7321937321937324,6.546335456512127,"['PSMD8', 'PSMB6', 'H2AFZ', 'HLA-B', 'PSMB10']",0.7216463330118176,0,0,5
40,Ciliary landscape WP4352,0.10556312632049114,2.0881022922189305,4.694985562375819,"['PSMD8', 'YAP1', 'EXOSC4', 'H3F3A', 'COPS7A', 'COX6C', 'LSM4']",0.815475150825794,0,0,7
41,Cytosolic DNA-sensing pathway WP4655,0.12714930109079775,2.340659340659341,4.827360103977613,"['TRADD', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.8338610894680335,0,0,5
42,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.1379223749074773,2.6197952218430034,5.189982663540018,"['PPP1CC', 'PPP1R14B', 'XBP1', 'DDIT3']",0.8338610894680335,0,0,4
43,Amyotrophic lateral sclerosis (ALS) WP2447,0.1392662425436124,6.540816326530612,12.894354455941635,"['BAX', 'SOD1']",0.8338610894680335,0,0,2
44,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.1392662425436124,6.540816326530612,12.894354455941635,"['HOMER1', 'HRAS']",0.8338610894680335,0,0,2
45,TP53 network WP1742,0.1392662425436124,6.540816326530612,12.894354455941635,"['GADD45A', 'BAX']",0.8338610894680335,0,0,2
46,Vitamin D-sensitive calcium signaling in depression WP4698,0.1392662425436124,6.540816326530612,12.894354455941635,"['CALB1', 'GPX4']",0.8338610894680335,0,0,2
47,EV release from cardiac cells and their functional effects WP3297,0.1392662425436124,6.540816326530612,12.894354455941635,"['CXCL12', 'RGS16']",0.8338610894680335,0,0,2
48,Mevalonate pathway WP3963,0.1392662425436124,6.540816326530612,12.894354455941635,"['HMGCS1', 'HMGCR']",0.8338610894680335,0,0,2
49,Nanoparticle triggered regulated necrosis WP2513,0.1392662425436124,6.540816326530612,12.894354455941635,"['TRADD', 'FADD']",0.8338610894680335,0,0,2
50,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.1392662425436124,6.540816326530612,12.894354455941635,"['YAP1', 'FERMT3']",0.8338610894680335,0,0,2
51,Glycolysis in senescence WP5049,0.14572329718858837,3.2725724020442932,6.303123938165466,"['LDHA', 'PKM', 'ALDOC']",0.8338610894680335,0,0,3
52,MET in type 1 papillary renal cell carcinoma WP4205,0.14572329718858837,3.2725724020442932,6.303123938165466,"['RPL11', 'ETS1', 'HRAS']",0.8338610894680335,0,0,3
53,Photodynamic therapy-induced unfolded protein response WP3613,0.14572329718858837,3.2725724020442932,6.303123938165466,"['XBP1', 'DDIT3', 'CALR']",0.8338610894680335,0,0,3
54,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.14572329718858837,3.2725724020442932,6.303123938165466,"['CXCL12', 'TRADD', 'FADD']",0.8338610894680335,0,0,3
55,16p11.2 proximal deletion syndrome WP4949,0.1686012523789033,2.047008547008547,3.6441231100652622,"['TCP1', 'KCTD13', 'SEZ6L2', 'CCT7', 'CDIPT']",0.8895439409007253,0,0,5
56,Apoptosis WP254,0.1891180593201263,2.182025028441411,3.6339091476332084,"['TRADD', 'CYCS', 'BAX', 'FADD']",0.8895439409007253,0,0,4
57,Non-small cell lung cancer WP4255,0.1891180593201263,2.182025028441411,3.6339091476332084,"['GADD45A', 'CYCS', 'BAX', 'HRAS']",0.8895439409007253,0,0,4
58,Amino Acid metabolism WP3925,0.21224667521796653,2.4531516183986373,3.8024000178200263,"['LDHA', 'PKM', 'ODC1']",0.8895439409007253,0,0,3
59,Leptin signaling pathway WP2034,0.21224667521796653,2.4531516183986373,3.8024000178200263,"['CFL2', 'BAX', 'HRAS']",0.8895439409007253,0,0,3
60,Mesodermal commitment pathway WP2857,0.21224667521796653,2.4531516183986373,3.8024000178200263,"['YAP1', 'SLC2A12', 'RPL38']",0.8895439409007253,0,0,3
61,Parkinson's disease pathway WP2371,0.21224667521796653,2.4531516183986373,3.8024000178200263,"['PINK1', 'CYCS', 'PARK7']",0.8895439409007253,0,0,3
62,15q11.2 copy number variation syndrome WP4940,0.234685524634866,inf,inf,['TUBGCP4'],0.8895439409007253,0,0,1
63,Serotonin Transporter Activity WP1455,0.234685524634866,inf,inf,['IL1R1'],0.8895439409007253,0,0,1
64,Vitamin B12 Disorders WP4271,0.234685524634866,inf,inf,['CUBN'],0.8895439409007253,0,0,1
65,Composition of Lipid Particles WP3601,0.234685524634866,inf,inf,['LDLR'],0.8895439409007253,0,0,1
66,Energy Metabolism WP1541,0.234685524634866,inf,inf,['UCP3'],0.8895439409007253,0,0,1
67,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.234685524634866,inf,inf,['MAFF'],0.8895439409007253,0,0,1
68,Glycerophospholipid Biosynthetic Pathway WP2533,0.234685524634866,inf,inf,['CDIPT'],0.8895439409007253,0,0,1
69,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.234685524634866,inf,inf,['ELOB'],0.8895439409007253,0,0,1
70,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.234685524634866,inf,inf,['HRAS'],0.8895439409007253,0,0,1
71,Mitochondrial CII Assembly WP4920,0.234685524634866,inf,inf,['SDHAF1'],0.8895439409007253,0,0,1
72,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.234685524634866,inf,inf,['LDHA'],0.8895439409007253,0,0,1
73,Target Of Rapamycin (TOR) Signaling WP1471,0.23606020438142225,3.2687074829931975,4.718929712431163,"['IDI1', 'HMGCR']",0.8895439409007253,0,0,2
74,Tumor suppressor activity of SMARCB1 WP4204,0.23606020438142225,3.2687074829931975,4.718929712431163,"['H3F3B', 'H3F3A']",0.8895439409007253,0,0,2
75,GABA receptor Signaling WP4159,0.23606020438142225,3.2687074829931975,4.718929712431163,"['SLC32A1', 'AP2M1']",0.8895439409007253,0,0,2
76,IL-1 signaling pathway WP195,0.23606020438142225,3.2687074829931975,4.718929712431163,"['IL1R1', 'HSPB2']",0.8895439409007253,0,0,2
77,Methionine De Novo and Salvage Pathway WP3580,0.23606020438142225,3.2687074829931975,4.718929712431163,"['AHCY', 'ODC1']",0.8895439409007253,0,0,2
78,Neovascularisation processes WP4331,0.23606020438142225,3.2687074829931975,4.718929712431163,"['CXCL12', 'PDGFB']",0.8895439409007253,0,0,2
79,Nucleotide metabolism WP404,0.23606020438142225,3.2687074829931975,4.718929712431163,"['NME2', 'OAZ1']",0.8895439409007253,0,0,2
80,Osteoclast Signaling WP12,0.23606020438142225,3.2687074829931975,4.718929712431163,"['ATP6V1G1', 'PDGFB']",0.8895439409007253,0,0,2
81,Oxidative Stress WP408,0.23606020438142225,3.2687074829931975,4.718929712431163,"['TXN2', 'SOD1']",0.8895439409007253,0,0,2
82,PDGF Pathway WP2526,0.23606020438142225,3.2687074829931975,4.718929712431163,"['PDGFB', 'HRAS']",0.8895439409007253,0,0,2
83,Translation Factors WP107,0.24513890911806424,1.8693320331545586,2.6281504585298467,"['EEF1B2', 'EEF1G', 'EIF3I', 'EIF4H']",0.8911520343233159,0,0,4
84,DNA damage response WP707,0.24513890911806424,1.8693320331545586,2.6281504585298467,"['GADD45A', 'CYCS', 'BAX', 'BRCA1']",0.8911520343233159,0,0,4
85,miRNA regulation of DNA damage response WP1530,0.24513890911806424,1.8693320331545586,2.6281504585298467,"['GADD45A', 'CYCS', 'BAX', 'BRCA1']",0.8911520343233159,0,0,4
86,DNA Repair Pathways Full Network WP4946,0.26366203176190456,1.6358974358974359,2.1807938974463905,"['NEIL2', 'CENPX', 'TDG', 'POLE3', 'BRCA1']",0.9089385130499854,0,0,5
87,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.2835729122974311,1.9614991482112436,2.4720499206940856,"['IFI27L2', 'ETS1', 'HRAS']",0.9089385130499854,0,0,3
88,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.2835729122974311,1.9614991482112436,2.4720499206940856,"['CXCL12', 'TRADD', 'FADD']",0.9089385130499854,0,0,3
89,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.2835729122974311,1.9614991482112436,2.4720499206940856,"['LDHA', 'PKM', 'BAX']",0.9089385130499854,0,0,3
90,Alzheimer's disease WP2059,0.3041337065763391,1.6348122866894197,1.945897201886913,"['ATP5MD', 'CYCS', 'CALM3', 'FADD']",0.9089385130499854,0,0,4
91,TNF-alpha signaling pathway WP231,0.3041337065763391,1.6348122866894197,1.945897201886913,"['TRADD', 'BAX', 'FADD', 'HRAS']",0.9089385130499854,0,0,4
92,Glycolysis and Gluconeogenesis WP534,0.3041337065763391,1.6348122866894197,1.945897201886913,"['LDHA', 'PKM', 'PGAM1', 'ALDOC']",0.9089385130499854,0,0,4
93,Apoptosis Modulation by HSP70 WP384,0.3348851866122016,2.1780045351473922,2.382666246940837,"['CYCS', 'FADD']",0.9089385130499854,0,0,2
94,Type 2 papillary renal cell carcinoma WP4241,0.3348851866122016,2.1780045351473922,2.382666246940837,"['PDGFB', 'ELOB']",0.9089385130499854,0,0,2
95,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.3348851866122016,2.1780045351473922,2.382666246940837,"['BANF1', 'HRAS']",0.9089385130499854,0,0,2
96,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3348851866122016,2.1780045351473922,2.382666246940837,"['BAX', 'FADD']",0.9089385130499854,0,0,2
97,Imatinib and Chronic Myeloid Leukemia WP3640,0.3348851866122016,2.1780045351473922,2.382666246940837,"['SPRED2', 'GADD45A']",0.9089385130499854,0,0,2
98,p53 transcriptional gene network WP4963,0.3348851866122016,2.1780045351473922,2.382666246940837,"['GADD45A', 'BAX']",0.9089385130499854,0,0,2
99,Base Excision Repair WP4752,0.3563981645735701,1.6337308347529813,1.6855311026219162,"['NEIL2', 'TDG', 'POLE3']",0.9089385130499854,0,0,3
100,Fas ligand pathway and stress induction of heat shock proteins WP314,0.3563981645735701,1.6337308347529813,1.6855311026219162,"['MAPKAPK3', 'CYCS', 'FADD']",0.9089385130499854,0,0,3
101,Ferroptosis WP4313,0.3563981645735701,1.6337308347529813,1.6855311026219162,"['MAP1LC3B', 'GPX4', 'VDAC2']",0.9089385130499854,0,0,3
102,Metabolic reprogramming in colon cancer WP4290,0.3563981645735701,1.6337308347529813,1.6855311026219162,"['LDHA', 'PKM', 'PGAM1']",0.9089385130499854,0,0,3
103,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.3563981645735701,1.6337308347529813,1.6855311026219162,"['YAP1', 'BAX', 'HRAS']",0.9089385130499854,0,0,3
104,Pathways in clear cell renal cell carcinoma WP4018,0.36437033865240276,1.4524080394387562,1.4663286656139418,"['LDHA', 'PKM', 'PDGFB', 'ALDOC']",0.9089385130499854,0,0,4
105,Senescence and Autophagy in Cancer WP615,0.36835786538802606,1.3075342465753426,1.3058349136834824,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'IGFBP5', 'HRAS', 'GABARAP']",0.9089385130499854,0,0,6
106,Serotonin and anxiety WP3947,0.41436518525586086,3.264855687606112,2.8763626866769236,['CRH'],0.9089385130499854,0,0,1
107,Serotonin and anxiety-related events WP3944,0.41436518525586086,3.264855687606112,2.8763626866769236,['CRH'],0.9089385130499854,0,0,1
108,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.41436518525586086,3.264855687606112,2.8763626866769236,['HRAS'],0.9089385130499854,0,0,1
109,Autophagy WP4923,0.41436518525586086,3.264855687606112,2.8763626866769236,['MAP1LC3B'],0.9089385130499854,0,0,1
110,Trans-sulfuration and one-carbon metabolism WP2525,0.41436518525586086,3.264855687606112,2.8763626866769236,['AHCY'],0.9089385130499854,0,0,1
111,Transcriptional cascade regulating adipogenesis WP4211,0.41436518525586086,3.264855687606112,2.8763626866769236,['DDIT3'],0.9089385130499854,0,0,1
112,Cysteine and methionine catabolism WP4504,0.41436518525586086,3.264855687606112,2.8763626866769236,['AHCY'],0.9089385130499854,0,0,1
113,Cytosine methylation WP3585,0.41436518525586086,3.264855687606112,2.8763626866769236,['TDG'],0.9089385130499854,0,0,1
114,Dopamine metabolism WP2436,0.41436518525586086,3.264855687606112,2.8763626866769236,['SOD1'],0.9089385130499854,0,0,1
115,Fluoropyrimidine Activity WP1601,0.41436518525586086,3.264855687606112,2.8763626866769236,['TDG'],0.9089385130499854,0,0,1
116,Gastric Cancer Network 2 WP2363,0.41436518525586086,3.264855687606112,2.8763626866769236,['SNURF'],0.9089385130499854,0,0,1
117,Glycerolipids and Glycerophospholipids WP4722,0.41436518525586086,3.264855687606112,2.8763626866769236,['CDIPT'],0.9089385130499854,0,0,1
118,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.41436518525586086,3.264855687606112,2.8763626866769236,['LTBP1'],0.9089385130499854,0,0,1
119,IL-2 signaling pathway WP49,0.41436518525586086,3.264855687606112,2.8763626866769236,['HRAS'],0.9089385130499854,0,0,1
120,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.41436518525586086,3.264855687606112,2.8763626866769236,['BAX'],0.9089385130499854,0,0,1
121,MAPK Cascade WP422,0.41436518525586086,3.264855687606112,2.8763626866769236,['HRAS'],0.9089385130499854,0,0,1
122,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.41436518525586086,3.264855687606112,2.8763626866769236,['AHCY'],0.9089385130499854,0,0,1
123,miR-509-3p alteration of YAP1/ECM axis WP3967,0.41436518525586086,3.264855687606112,2.8763626866769236,['YAP1'],0.9089385130499854,0,0,1
124,miRNA regulation of p53 pathway in prostate cancer WP3982,0.41436518525586086,3.264855687606112,2.8763626866769236,['BAX'],0.9089385130499854,0,0,1
125,Monoamine Transport WP727,0.41436518525586086,3.264855687606112,2.8763626866769236,['IL1R1'],0.9089385130499854,0,0,1
126,MTHFR deficiency WP4288,0.41436518525586086,3.264855687606112,2.8763626866769236,['CYCS'],0.9089385130499854,0,0,1
127,Osteoblast Signaling WP322,0.41436518525586086,3.264855687606112,2.8763626866769236,['PDGFB'],0.9089385130499854,0,0,1
128,Overview of nanoparticle effects WP3287,0.41436518525586086,3.264855687606112,2.8763626866769236,['BAX'],0.9089385130499854,0,0,1
129,PDGFR-beta pathway WP3972,0.41436518525586086,3.264855687606112,2.8763626866769236,['HRAS'],0.9089385130499854,0,0,1
130,Peroxiredoxin 2 induced ovarian failure WP4873,0.41436518525586086,3.264855687606112,2.8763626866769236,['BAX'],0.9089385130499854,0,0,1
131,PKC-gamma calcium signaling pathway in ataxia WP4760,0.41436518525586086,3.264855687606112,2.8763626866769236,['TRPC3'],0.9089385130499854,0,0,1
132,RalA downstream regulated genes WP2290,0.41436518525586086,3.264855687606112,2.8763626866769236,['HRAS'],0.9089385130499854,0,0,1
133,"Relationship between inflammation, COX-2 and EGFR WP4483",0.41436518525586086,3.264855687606112,2.8763626866769236,['HRAS'],0.9089385130499854,0,0,1
134,Exercise-induced Circadian Regulation WP410,0.42432999433673374,1.3064846416382252,1.1199759083940453,"['DNAJA1', 'IDI1', 'GSTP1', 'UCP3']",0.9089385130499854,0,0,4
135,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.42808961189449274,1.3996106108542223,1.1874614578201668,"['GADD45A', 'CYCS', 'BAX']",0.9089385130499854,0,0,3
136,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.42808961189449274,1.3996106108542223,1.1874614578201668,"['PDGFB', 'BAX', 'HRAS']",0.9089385130499854,0,0,3
137,Endometrial cancer WP4155,0.42808961189449274,1.3996106108542223,1.1874614578201668,"['GADD45A', 'BAX', 'HRAS']",0.9089385130499854,0,0,3
138,IL-18 signaling pathway WP4754,0.42912173801269515,1.123272884283247,0.9503052921462236,"['ARL4D', 'IMP3', 'TMSB4X', 'RGS16', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'FADD', 'RND2', 'ITM2C']",0.9089385130499854,0,0,11
139,Sleep regulation WP3591,0.4294660935446533,1.6326530612244898,1.3799387505162044,"['AHCY', 'CRH']",0.9089385130499854,0,0,2
140,ATM Signaling Pathway WP2516,0.4294660935446533,1.6326530612244898,1.3799387505162044,"['GADD45A', 'BRCA1']",0.9089385130499854,0,0,2
141,Unfolded protein response WP4925,0.4294660935446533,1.6326530612244898,1.3799387505162044,"['XBP1', 'DDIT3']",0.9089385130499854,0,0,2
142,Cori Cycle WP1946,0.4294660935446533,1.6326530612244898,1.3799387505162044,"['LDHA', 'PGAM1']",0.9089385130499854,0,0,2
143,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.4294660935446533,1.6326530612244898,1.3799387505162044,"['CD63', 'SOD1']",0.9089385130499854,0,0,2
144,Integrated Cancer Pathway WP1971,0.4294660935446533,1.6326530612244898,1.3799387505162044,"['BAX', 'BRCA1']",0.9089385130499854,0,0,2
145,One-carbon metabolism and related pathways WP3940,0.4294660935446533,1.6326530612244898,1.3799387505162044,"['GPX4', 'SOD1']",0.9089385130499854,0,0,2
146,Pathways affected in adenoid cystic carcinoma WP3651,0.4294660935446533,1.6326530612244898,1.3799387505162044,"['BRCA1', 'HRAS']",0.9089385130499854,0,0,2
147,Hepatitis B infection WP4666,0.48275468164850915,1.187092770710518,0.8644963451983103,"['CYCS', 'BAX', 'FADD', 'HRAS']",0.9230294107086899,0,0,4
148,Endoderm differentiation WP2853,0.4966960914189162,1.2240204429301533,0.8565412629123847,"['TCEAL2', 'SLC2A12', 'NME1']",0.9230294107086899,0,0,3
149,Circadian rhythm related genes WP3594,0.5083128889356643,1.0878995433789955,0.7361360357342637,"['PPP1CC', 'AHCY', 'HOMER1', 'CRH', 'RPS27A', 'UBA52']",0.9230294107086899,0,0,6
150,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.5163538117058222,1.3054421768707483,0.8628490648490297,"['HRAS', 'LTBP1']",0.9230294107086899,0,0,2
151,TGF-beta Receptor Signaling WP560,0.5163538117058222,1.3054421768707483,0.8628490648490297,"['HRAS', 'LTBP1']",0.9230294107086899,0,0,2
152,Computational Model of Aerobic Glycolysis WP4629,0.5163538117058222,1.3054421768707483,0.8628490648490297,"['LDHA', 'PKM']",0.9230294107086899,0,0,2
153,DNA Replication WP466,0.5163538117058222,1.3054421768707483,0.8628490648490297,"['GMNN', 'UBA52']",0.9230294107086899,0,0,2
154,Galanin receptor pathway WP4970,0.5163538117058222,1.3054421768707483,0.8628490648490297,"['YAP1', 'VAMP2']",0.9230294107086899,0,0,2
155,Genes controlling nephrogenesis WP4823,0.5163538117058222,1.3054421768707483,0.8628490648490297,"['CXCL12', 'PDGFB']",0.9230294107086899,0,0,2
156,MECP2 and Associated Rett Syndrome WP3584,0.5163538117058222,1.3054421768707483,0.8628490648490297,"['GABRR2', 'OPRK1']",0.9230294107086899,0,0,2
157,PPAR signaling pathway WP3942,0.5163538117058222,1.3054421768707483,0.8628490648490297,"['FABP6', 'CPT1B']",0.9230294107086899,0,0,2
158,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5519145413792097,1.631578947368421,0.9697486258948705,['HRAS'],0.9230294107086899,0,0,1
159,Angiogenesis WP1539,0.5519145413792097,1.631578947368421,0.9697486258948705,['PDGFB'],0.9230294107086899,0,0,1
160,Trans-sulfuration pathway WP2333,0.5519145413792097,1.631578947368421,0.9697486258948705,['AHCY'],0.9230294107086899,0,0,1
161,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.5519145413792097,1.631578947368421,0.9697486258948705,['VIP'],0.9230294107086899,0,0,1
162,Dual hijack model of Vif in HIV infection WP3300,0.5519145413792097,1.631578947368421,0.9697486258948705,['ELOB'],0.9230294107086899,0,0,1
163,Ebstein-Barr virus LMP1 signaling WP262,0.5519145413792097,1.631578947368421,0.9697486258948705,['TRADD'],0.9230294107086899,0,0,1
164,EDA signaling in hair follicle development WP3930,0.5519145413792097,1.631578947368421,0.9697486258948705,['SOSTDC1'],0.9230294107086899,0,0,1
165,Ethanol effects on histone modifications WP3996,0.5519145413792097,1.631578947368421,0.9697486258948705,['AHCY'],0.9230294107086899,0,0,1
166,Fatty acid transporters WP5061,0.5519145413792097,1.631578947368421,0.9697486258948705,['FABP6'],0.9230294107086899,0,0,1
167,Gastric acid production WP2596,0.5519145413792097,1.631578947368421,0.9697486258948705,['VIP'],0.9230294107086899,0,0,1
168,Gastric Cancer Network 1 WP2361,0.5519145413792097,1.631578947368421,0.9697486258948705,['H3F3A'],0.9230294107086899,0,0,1
169,Genes targeted by miRNAs in adipocytes WP1992,0.5519145413792097,1.631578947368421,0.9697486258948705,['TMSB4X'],0.9230294107086899,0,0,1
170,Glutathione metabolism WP100,0.5519145413792097,1.631578947368421,0.9697486258948705,['GPX4'],0.9230294107086899,0,0,1
171,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5519145413792097,1.631578947368421,0.9697486258948705,['LDHA'],0.9230294107086899,0,0,1
172,HIF1A and PPARG regulation of glycolysis WP2456,0.5519145413792097,1.631578947368421,0.9697486258948705,['LDHA'],0.9230294107086899,0,0,1
173,IL1 and megakaryocytes in obesity WP2865,0.5519145413792097,1.631578947368421,0.9697486258948705,['IL1R1'],0.9230294107086899,0,0,1
174,Interleukin-11 Signaling Pathway WP2332,0.5519145413792097,1.631578947368421,0.9697486258948705,['HRAS'],0.9230294107086899,0,0,1
175,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5519145413792097,1.631578947368421,0.9697486258948705,['HRAS'],0.9230294107086899,0,0,1
176,Kit receptor signaling pathway WP304,0.5519145413792097,1.631578947368421,0.9697486258948705,['HRAS'],0.9230294107086899,0,0,1
177,Matrix Metalloproteinases WP129,0.5519145413792097,1.631578947368421,0.9697486258948705,['MMP21'],0.9230294107086899,0,0,1
178,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.5519145413792097,1.631578947368421,0.9697486258948705,['LDLR'],0.9230294107086899,0,0,1
179,Nanoparticle-mediated activation of receptor signaling WP2643,0.5519145413792097,1.631578947368421,0.9697486258948705,['HRAS'],0.9230294107086899,0,0,1
180,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.5519145413792097,1.631578947368421,0.9697486258948705,['EIF3I'],0.9230294107086899,0,0,1
181,One-carbon metabolism WP241,0.5519145413792097,1.631578947368421,0.9697486258948705,['AHCY'],0.9230294107086899,0,0,1
182,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5519145413792097,1.631578947368421,0.9697486258948705,['HRAS'],0.9230294107086899,0,0,1
183,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5519145413792097,1.631578947368421,0.9697486258948705,['BAX'],0.9230294107086899,0,0,1
184,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.5519145413792097,1.631578947368421,0.9697486258948705,['CALM3'],0.9230294107086899,0,0,1
185,Myometrial relaxation and contraction pathways WP289,0.5526227863466266,1.0301009372746937,0.6109318853682083,"['IGFBP5', 'RGS16', 'MAFF', 'CRH', 'CALM3', 'IGFBP6']",0.9230294107086899,0,0,6
186,Acute viral myocarditis WP4298,0.5608835130413556,1.087450312322544,0.6288094833611815,"['ENDOG', 'CYCS', 'BAX']",0.9268075162020262,0,0,3
187,DNA damage response (only ATM dependent) WP710,0.5608835130413556,1.087450312322544,0.6288094833611815,"['BAX', 'HRAS', 'LDLR']",0.9268075162020262,0,0,3
188,Thermogenesis WP4321,0.5939473882229005,1.0873015873015872,0.5664455664395515,"['CPT1B', 'HRAS']",0.9424051924268715,0,0,2
189,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5939473882229005,1.0873015873015872,0.5664455664395515,"['MAPKAPK3', 'HRAS']",0.9424051924268715,0,0,2
190,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5939473882229005,1.0873015873015872,0.5664455664395515,"['HRAS', 'MYL12B']",0.9424051924268715,0,0,2
191,Fragile X Syndrome  WP4549,0.5939473882229005,1.0873015873015872,0.5664455664395515,"['HOMER1', 'AP2M1']",0.9424051924268715,0,0,2
192,Regulation of Actin Cytoskeleton WP51,0.619837420590433,0.9781942078364566,0.4678683920914885,"['CFL2', 'TMSB4X', 'PDGFB']",0.9424051924268715,0,0,3
193,Signal transduction through IL1R WP4496,0.6571992161265224,1.0871533672891907,0.4563522877046602,['IL1R1'],0.9424051924268715,0,0,1
194,Bile acids synthesis and enterohepatic circulation  WP4389,0.6571992161265224,1.0871533672891907,0.4563522877046602,['LDLR'],0.9424051924268715,0,0,1
195,CAMKK2  Pathway WP4874,0.6571992161265224,1.0871533672891907,0.4563522877046602,['FIS1'],0.9424051924268715,0,0,1
196,White fat cell differentiation WP4149,0.6571992161265224,1.0871533672891907,0.4563522877046602,['DDIT3'],0.9424051924268715,0,0,1
197,Disruption of postsynaptic signaling by CNV WP4875,0.6571992161265224,1.0871533672891907,0.4563522877046602,['HOMER1'],0.9424051924268715,0,0,1
198,ERK Pathway in Huntington's Disease WP3853,0.6571992161265224,1.0871533672891907,0.4563522877046602,['HRAS'],0.9424051924268715,0,0,1
199,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6571992161265224,1.0871533672891907,0.4563522877046602,['HRAS'],0.9424051924268715,0,0,1
200,Fatty acid beta-oxidation WP143,0.6571992161265224,1.0871533672891907,0.4563522877046602,['CPT1B'],0.9424051924268715,0,0,1
201,Glycosylation and related congenital defects WP4521,0.6571992161265224,1.0871533672891907,0.4563522877046602,['DPM3'],0.9424051924268715,0,0,1
202,"GPCRs, Class B Secretin-like WP334",0.6571992161265224,1.0871533672891907,0.4563522877046602,['CALCR'],0.9424051924268715,0,0,1
203,Major receptors targeted by epinephrine and norepinephrine WP4589,0.6571992161265224,1.0871533672891907,0.4563522877046602,['ADRA2A'],0.9424051924268715,0,0,1
204,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6571992161265224,1.0871533672891907,0.4563522877046602,['VEGFB'],0.9424051924268715,0,0,1
205,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6571992161265224,1.0871533672891907,0.4563522877046602,['SCO2'],0.9424051924268715,0,0,1
206,Netrin-UNC5B signaling pathway WP4747,0.6571992161265224,1.0871533672891907,0.4563522877046602,['YAP1'],0.9424051924268715,0,0,1
207,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6571992161265224,1.0871533672891907,0.4563522877046602,['PDGFB'],0.9424051924268715,0,0,1
208,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6571992161265224,1.0871533672891907,0.4563522877046602,['BAX'],0.9424051924268715,0,0,1
209,Regulation of Microtubule Cytoskeleton WP2038,0.6571992161265224,1.0871533672891907,0.4563522877046602,['CFL2'],0.9424051924268715,0,0,1
210,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.6571992161265224,1.0871533672891907,0.4563522877046602,['ANAPC11'],0.9424051924268715,0,0,1
211,NRF2 pathway WP2884,0.6576221901004247,0.9050332383665717,0.37932177704438746,"['PRDX1', 'GSTP1', 'MAFF', 'SLC2A12', 'PDGFB']",0.9424051924268715,0,0,5
212,AGE/RAGE pathway WP2324,0.661818533192981,0.9314868804664723,0.384484138639746,"['CYCS', 'SOD1']",0.9424051924268715,0,0,2
213,AMP-activated protein kinase (AMPK) signaling WP1403,0.661818533192981,0.9314868804664723,0.384484138639746,"['HMGCR', 'CPT1B']",0.9424051924268715,0,0,2
214,ESC Pluripotency Pathways WP3931,0.661818533192981,0.9314868804664723,0.384484138639746,"['PDGFB', 'HRAS']",0.9424051924268715,0,0,2
215,Head and Neck Squamous Cell Carcinoma WP4674,0.661818533192981,0.9314868804664723,0.384484138639746,"['FADD', 'HRAS']",0.9424051924268715,0,0,2
216,Hippo-Merlin Signaling Dysregulation WP4541,0.661818533192981,0.9314868804664723,0.384484138639746,"['PPP1CC', 'HRAS']",0.9424051924268715,0,0,2
217,Modulators of TCR signaling and T cell activation WP5072,0.661818533192981,0.9314868804664723,0.384484138639746,"['NDUFB10', 'ELOB']",0.9424051924268715,0,0,2
218,22q11.2 copy number variation syndrome WP4657,0.7202506980998982,0.814625850340136,0.2673243082218754,"['RANBP1', 'MRPL40']",0.9538688082607145,0,0,2
219,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7202506980998982,0.814625850340136,0.2673243082218754,"['BEX3', 'ETS1']",0.9538688082607145,0,0,2
220,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7202506980998982,0.814625850340136,0.2673243082218754,"['TMSB4X', 'SOD1']",0.9538688082607145,0,0,2
221,Oncostatin M Signaling Pathway WP2374,0.7202506980998982,0.814625850340136,0.2673243082218754,"['HRAS', 'LDLR']",0.9538688082607145,0,0,2
222,Prader-Willi and Angelman Syndrome WP3998,0.7202506980998982,0.814625850340136,0.2673243082218754,"['GABRR2', 'SNURF']",0.9538688082607145,0,0,2
223,Complement system WP2806,0.7207582524322194,0.8143100511073254,0.266647041792039,"['RPS19', 'CD59', 'CALR']",0.9538688082607145,0,0,3
224,7-oxo-C and 7beta-HC pathways WP5064,0.737777622477052,0.8149405772495756,0.24783388062142267,['ACOT11'],0.9538688082607145,0,0,1
225,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.737777622477052,0.8149405772495756,0.24783388062142267,['IL1R1'],0.9538688082607145,0,0,1
226,ATM Signaling Network in Development and Disease  WP3878,0.737777622477052,0.8149405772495756,0.24783388062142267,['KAT5'],0.9538688082607145,0,0,1
227,Cardiac Progenitor Differentiation WP2406,0.737777622477052,0.8149405772495756,0.24783388062142267,['MESP1'],0.9538688082607145,0,0,1
228,Urea cycle and metabolism of amino groups WP497,0.737777622477052,0.8149405772495756,0.24783388062142267,['ODC1'],0.9538688082607145,0,0,1
229,DNA Mismatch Repair WP531,0.737777622477052,0.8149405772495756,0.24783388062142267,['POLE3'],0.9538688082607145,0,0,1
230,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.737777622477052,0.8149405772495756,0.24783388062142267,['IGFBP5'],0.9538688082607145,0,0,1
231,Heart Development WP1591,0.737777622477052,0.8149405772495756,0.24783388062142267,['VEGFB'],0.9538688082607145,0,0,1
232,IL-6 signaling pathway WP364,0.737777622477052,0.8149405772495756,0.24783388062142267,['VIP'],0.9538688082607145,0,0,1
233,Integrin-mediated Cell Adhesion WP185,0.737777622477052,0.8149405772495756,0.24783388062142267,['HRAS'],0.9538688082607145,0,0,1
234,Joubert Syndrome WP4656,0.737777622477052,0.8149405772495756,0.24783388062142267,['KAT5'],0.9538688082607145,0,0,1
235,NO/cGMP/PKG mediated Neuroprotection WP4008,0.737777622477052,0.8149405772495756,0.24783388062142267,['CYCS'],0.9538688082607145,0,0,1
236,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.737777622477052,0.8149405772495756,0.24783388062142267,['GSTP1'],0.9538688082607145,0,0,1
237,Pre-implantation embryo WP3527,0.737777622477052,0.8149405772495756,0.24783388062142267,['DDIT3'],0.9538688082607145,0,0,1
238,RANKL/RANK signaling pathway WP2018,0.737777622477052,0.8149405772495756,0.24783388062142267,['CALCR'],0.9538688082607145,0,0,1
239,EGF/EGFR signaling pathway WP437,0.7627808139693748,0.7512776831345827,0.20343439512520084,"['NDUFA13', 'HRAS', 'AP2M1']",0.9538688082607145,0,0,3
240,Insulin Signaling WP481,0.7627808139693748,0.7512776831345827,0.20343439512520084,"['XBP1', 'HRAS', 'VAMP2']",0.9538688082607145,0,0,3
241,Proximal tubule transport WP4917,0.7627808139693748,0.7512776831345827,0.20343439512520084,"['ATP6V1G1', 'SLC13A3', 'ATP6V1F']",0.9538688082607145,0,0,3
242,Chemokine signaling pathway WP3929,0.7699294316611716,0.7237339380196524,0.18922488123025766,"['CXCL12', 'HRAS']",0.9538688082607145,0,0,2
243,Ebola Virus Pathway on Host WP4217,0.7699294316611716,0.7237339380196524,0.18922488123025766,"['HLA-B', 'CLEC4G']",0.9538688082607145,0,0,2
244,Glioblastoma signaling pathways WP2261,0.7699294316611716,0.7237339380196524,0.18922488123025766,"['BRCA1', 'HRAS']",0.9538688082607145,0,0,2
245,Oxidative Damage WP3941,0.7699294316611716,0.7237339380196524,0.18922488123025766,"['GADD45A', 'CYCS']",0.9538688082607145,0,0,2
246,Pancreatic adenocarcinoma pathway WP4263,0.7699294316611716,0.7237339380196524,0.18922488123025766,"['GADD45A', 'BAX']",0.9538688082607145,0,0,2
247,Peptide GPCRs WP24,0.7699294316611716,0.7237339380196524,0.18922488123025766,"['NPY1R', 'OPRK1']",0.9538688082607145,0,0,2
248,MAPK Signaling Pathway WP382,0.7974915037380343,0.75,0.16971307349993045,"['MAPKAPK3', 'IL1R1', 'GADD45A', 'DDIT3', 'PDGFB', 'HRAS']",0.9538688082607145,0,0,6
249,Alpha 6 Beta 4 signaling pathway WP244,0.7994398282503132,0.6516129032258065,0.14585964605082719,['HRAS'],0.9538688082607145,0,0,1
250,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7994398282503132,0.6516129032258065,0.14585964605082719,['HRAS'],0.9538688082607145,0,0,1
251,Aryl Hydrocarbon Receptor Netpath WP2586,0.7994398282503132,0.6516129032258065,0.14585964605082719,['HRAS'],0.9538688082607145,0,0,1
252,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7994398282503132,0.6516129032258065,0.14585964605082719,['FADD'],0.9538688082607145,0,0,1
253,Common Pathways Underlying Drug Addiction WP2636,0.7994398282503132,0.6516129032258065,0.14585964605082719,['PPP1CC'],0.9538688082607145,0,0,1
254,DNA IR-damage and cellular response via ATR WP4016,0.7994398282503132,0.6516129032258065,0.14585964605082719,['BRCA1'],0.9538688082607145,0,0,1
255,Endothelin Pathways WP2197,0.7994398282503132,0.6516129032258065,0.14585964605082719,['NPY1R'],0.9538688082607145,0,0,1
256,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7994398282503132,0.6516129032258065,0.14585964605082719,['DDIT3'],0.9538688082607145,0,0,1
257,Nucleotide Excision Repair WP4753,0.7994398282503132,0.6516129032258065,0.14585964605082719,['POLE3'],0.9538688082607145,0,0,1
258,Oxysterols derived from cholesterol WP4545,0.7994398282503132,0.6516129032258065,0.14585964605082719,['ACOT11'],0.9538688082607145,0,0,1
259,Small cell lung cancer WP4658,0.7995211046586571,0.697249939157946,0.15600433973970365,"['GADD45A', 'CYCS', 'BAX']",0.9538688082607145,0,0,3
260,Breast cancer pathway WP4262,0.8246463160196773,0.6843901562780672,0.13195089601849722,"['GADD45A', 'BAX', 'BRCA1', 'HRAS']",0.9653451774792203,0,0,4
261,Adipogenesis WP236,0.8313715065553223,0.6504258943781942,0.1201196944018764,"['GADD45A', 'DDIT3', 'MIF']",0.9653451774792203,0,0,3
262,Focal Adhesion WP306,0.8459754406749952,0.6766381766381766,0.11317785060232914,"['PPP1CC', 'PDGFB', 'VEGFB', 'HRAS', 'MYL12B']",0.9653451774792203,0,0,5
263,Type II interferon signaling (IFNG) WP619,0.8466207317285953,0.5427277872099604,0.09036551329451963,['HLA-B'],0.9653451774792203,0,0,1
264,Differentiation Pathway WP2848,0.8466207317285953,0.5427277872099604,0.09036551329451963,['PDGFB'],0.9653451774792203,0,0,1
265,G13 Signaling Pathway WP524,0.8466207317285953,0.5427277872099604,0.09036551329451963,['CFL2'],0.9653451774792203,0,0,1
266,Hepatitis C and Hepatocellular Carcinoma WP3646,0.8466207317285953,0.5427277872099604,0.09036551329451963,['BRCA1'],0.9653451774792203,0,0,1
267,Hypertrophy Model WP516,0.8466207317285953,0.5427277872099604,0.09036551329451963,['IL1R1'],0.9653451774792203,0,0,1
268,IL-3 signaling pathway WP286,0.8466207317285953,0.5427277872099604,0.09036551329451963,['HRAS'],0.9653451774792203,0,0,1
269,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8466207317285953,0.5427277872099604,0.09036551329451963,['BAX'],0.9653451774792203,0,0,1
270,B Cell Receptor Signaling Pathway WP23,0.8466295893102547,0.5915275200989487,0.09848460031984821,"['ETS1', 'HRAS']",0.9653451774792203,0,0,2
271,Gastrin signaling pathway WP4659,0.8466295893102547,0.5915275200989487,0.09848460031984821,"['KAT5', 'HRAS']",0.9653451774792203,0,0,2
272,Ras signaling WP4223,0.8587764305179634,0.6094548551959114,0.0927874649197563,"['CALM3', 'ETS1', 'HRAS']",0.9706743742065879,0,0,3
273,"GPCRs, Class A Rhodopsin-like WP455",0.8670697109905646,0.6492307692307693,0.09260361546677491,"['NPFFR1', 'NPY1R', 'OPRK1', 'OR6A2', 'ADRA2A']",0.9706743742065879,0,0,5
274,TGF-beta Signaling Pathway WP366,0.8755415206428483,0.5419501133786848,0.07203205463241058,"['YAP1', 'ETS1']",0.9706743742065879,0,0,2
275,Cell cycle WP179,0.8821993423530223,0.5733039382703677,0.0718563314544772,"['GADD45A', 'CDC14A', 'ANAPC11']",0.9706743742065879,0,0,3
276,Aryl Hydrocarbon Receptor Pathway WP2873,0.8827168257347936,0.46495270434149893,0.05800323367069767,['BAX'],0.9706743742065879,0,0,1
277,Bladder cancer WP2828,0.8827168257347936,0.46495270434149893,0.05800323367069767,['HRAS'],0.9706743742065879,0,0,1
278,Toll-like Receptor Signaling Pathway WP75,0.8827168257347936,0.46495270434149893,0.05800323367069767,['FADD'],0.9706743742065879,0,0,1
279,Glycogen Synthesis and Degradation WP500,0.8827168257347936,0.46495270434149893,0.05800323367069767,['CALM3'],0.9706743742065879,0,0,1
280,Monoamine GPCRs WP58,0.8827168257347936,0.46495270434149893,0.05800323367069767,['ADRA2A'],0.9706743742065879,0,0,1
281,Prolactin Signaling Pathway WP2037,0.8827168257347936,0.46495270434149893,0.05800323367069767,['HRAS'],0.9706743742065879,0,0,1
282,Vitamin D Receptor Pathway WP2877,0.8919139464308674,0.5901334160719827,0.06750277884415722,"['IGFBP5', 'GADD45A', 'SOSTDC1', 'ZNF257']",0.9733275641603621,0,0,4
283,Spinal Cord Injury WP2431,0.9020993098320641,0.5411697898921067,0.055757083540435355,"['IL1R1', 'GADD45A', 'MIF']",0.9733275641603621,0,0,3
284,ErbB signaling pathway WP673,0.9103290163182676,0.4066213921901528,0.038201749791818576,['HRAS'],0.9733275641603621,0,0,1
285,G Protein Signaling Pathways WP35,0.9103290163182676,0.4066213921901528,0.038201749791818576,['HRAS'],0.9733275641603621,0,0,1
286,G1 to S cell cycle control WP45,0.9103290163182676,0.4066213921901528,0.038201749791818576,['GADD45A'],0.9733275641603621,0,0,1
287,Nephrotic syndrome WP4758,0.9103290163182676,0.4066213921901528,0.038201749791818576,['CUBN'],0.9733275641603621,0,0,1
288,Neural Crest Differentiation WP2064,0.9103290163182676,0.4066213921901528,0.038201749791818576,['ETS1'],0.9733275641603621,0,0,1
289,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.9103290163182676,0.4066213921901528,0.038201749791818576,['NDUFA13'],0.9733275641603621,0,0,1
290,Allograft Rejection WP2328,0.9188646849558405,0.4640427599611273,0.03926563200865842,"['CXCL12', 'HLA-B']",0.9757402611723758,0,0,2
291,Corticotropin-releasing hormone signaling pathway WP2355,0.9314487361492094,0.36125259385021696,0.025654036535152136,['CRH'],0.9757402611723758,0,0,1
292,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9314487361492094,0.36125259385021696,0.025654036535152136,['HMGCS1'],0.9757402611723758,0,0,1
293,Endochondral Ossification WP474,0.9314487361492094,0.36125259385021696,0.025654036535152136,['HMGCS1'],0.9757402611723758,0,0,1
294,Lung fibrosis WP3624,0.9314487361492094,0.36125259385021696,0.025654036535152136,['PDGFB'],0.9757402611723758,0,0,1
295,Calcium Regulation in the Cardiac Cell WP536,0.9448928862887017,0.46312971525918717,0.026251908506329396,"['RGS16', 'CALM3', 'CALR']",0.9757402611723758,0,0,3
296,T-cell receptor (TCR) signaling pathway WP69,0.9476005765381932,0.32495755517826824,0.017489929966844057,['HRAS'],0.9757402611723758,0,0,1
297,TYROBP causal network in microglia WP3945,0.9476005765381932,0.32495755517826824,0.017489929966844057,['LOXL3'],0.9757402611723758,0,0,1
298,Wnt signaling pathway and pluripotency WP399,0.9476005765381932,0.32495755517826824,0.017489929966844057,['LDLR'],0.9757402611723758,0,0,1
299,Retinoblastoma gene in cancer WP2446,0.9476005765381932,0.32495755517826824,0.017489929966844057,['H2AFZ'],0.9757402611723758,0,0,1
300,Metapathway biotransformation Phase I and II WP702,0.958164581456878,0.38155262104841936,0.016305925535344355,"['GPX4', 'GSTP1']",0.9757402611723758,0,0,2
301,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.958164581456878,0.38155262104841936,0.016305925535344355,"['PSMD8', 'STUB1']",0.9757402611723758,0,0,2
302,Ciliopathies WP4803,0.959951583807127,0.29526161444667387,0.012068059469244257,['AK7'],0.9757402611723758,0,0,1
303,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.959951583807127,0.29526161444667387,0.012068059469244257,['HRAS'],0.9757402611723758,0,0,1
304,Regulation of toll-like receptor signaling pathway WP1449,0.959951583807127,0.29526161444667387,0.012068059469244257,['FADD'],0.9757402611723758,0,0,1
305,Nuclear Receptors Meta-Pathway WP2882,0.9822686345403645,0.4603718199608611,0.008236258769957297,"['PRDX1', 'GSTP1', 'SLC2A12', 'MAFF', 'PDGFB', 'BAX']",0.9951508461408939,0,0,6
306,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9895740261374981,0.20246179966044142,0.0021219424117702077,['HRAS'],0.9984220917182757,0,0,1
307,PI3K-Akt signaling pathway WP4172,0.9946563707312424,0.33878210885575716,0.0018151801483546844,"['PDGFB', 'VEGFB', 'BRCA1', 'HRAS']",0.9984220917182757,0,0,4
308,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9955183731507928,0.2928604615146353,0.0013154411722984239,"['PDGFB', 'VEGFB', 'HRAS']",0.9984220917182757,0,0,3
309,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9984220917182757,0.1403262714992249,0.00022159686171764292,['VAMP2'],0.9984220917182757,0,0,1
